FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation.
about
Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisLoss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia.Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia PatientsHoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid LeukemiaSAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expressionThe combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets.SOX12: a novel potential target for acute myeloid leukaemia.Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanismIbrutinib selectively targets FLT3-ITD in mutant FLT3-positive AML.Impact of phosphoproteomics in the translation of kinase-targeted therapies.An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemiaDrug Repurposing for the Treatment of Acute Myeloid Leukemia.5D proteomic approach for the biomarker search in plasma: Acute myeloid leukaemia as a case study.AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.Role and regulation of microRNAs targeting BTK in acute myelogenous leukemia.Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.
P2860
Q26797245-BFC275FB-7DE2-4EE7-9027-3683F684A45BQ30313615-564E64EF-5822-47BC-B91E-489B58F1EF08Q33555287-84DD0571-5C33-4C1A-BA8C-F1F81EE0ECBAQ33558976-402B1444-6A83-4338-862A-9A204EF2C37DQ34547626-F0DFC797-5438-475C-ACF9-3E64CCB4CA08Q35979385-D1BC698B-4F6A-4B57-B6E4-85EC431CCAC7Q37150541-315381E2-CDF7-478A-A17F-856D3F614D4EQ37706488-A00598A1-7638-44AC-B176-EBE2CD7838EEQ38384041-FA12F6E8-B48C-4657-85D2-EC9128A06A55Q38730529-9843AB07-1D47-4815-B12E-D222B56E9FABQ38815360-6EE8D462-8020-4DE4-AC27-CD1F4E51C87CQ38857067-91D91DF3-1F7C-4287-91F7-8B41B3FE13FCQ38989188-2EEC833E-D096-4EFD-A470-0A9A0A9FB234Q41819724-D3E71487-1870-4DE1-A096-B7B7BCCBBB44Q47094576-4A3E353E-3FE3-4271-A335-E3582E2C2E0FQ47101230-21C7A626-1FBA-48CB-A0E1-DD467E82C883Q47565832-883321A7-BC3F-4F00-B3A9-803E2BC2557EQ50054874-796BF7CF-2907-4D87-BEDD-888E65DEA601Q50131810-192ED844-C8C1-4A64-8D0A-FCFA4C480CFF
P2860
FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
FLT3-ITD and TLR9 use Bruton t ...... ll survival and proliferation.
@en
type
label
FLT3-ITD and TLR9 use Bruton t ...... ll survival and proliferation.
@en
prefLabel
FLT3-ITD and TLR9 use Bruton t ...... ll survival and proliferation.
@en
P2093
P1433
P1476
FLT3-ITD and TLR9 use Bruton t ...... ell survival and proliferation
@en
P2093
Anjali Cremer
Carmen Döbele
Christina Perske
Ekkehard Schütz
Gesine Bug
Hanibal Bohnenberger
Helene Braun
Henning Urlaub
Jasmin Corso
Johannes Wicht
P304
P356
10.1182/BLOOD-2014-06-585216
P407
P50
P577
2015-01-20T00:00:00Z